Lung cancer accounts for nearly 20% of annual cancer-related deaths worldwide. According to 2022 statistics from the Swiss Cancer League, nearly 5,000 new cases of lung cancer are reported in Switzerland each year. Over the ...
Jan 8, 2024
0
0
At EPFL's School of Engineering, Professor Li Tang's Laboratory of Biomaterials for Immunoengineering has made significant strides in cancer treatment research. In laboratory settings, this innovative CAR-T therapy has consistently ...
Jan 4, 2024
0
19
In a paper published in npj Imaging, King's researchers have assessed the use of fertilized chicken eggs as an alternative model that can resolve both ethical and economic issues for preclinical cancer research.
Jan 4, 2024
0
46
Recent advances in treating multiple myeloma, the second most common blood cancer, and other blood malignancies are providing improved outcomes—and hope—to patients worldwide.
Jan 4, 2024
0
3
Nearly half of all cancer patients undergo radiation therapy as part of their care. Ionizing radiation, or the emission of high-energy waves or particles, works as a therapy by damaging a cancer cell's DNA. It's an effective ...
Jan 4, 2024
0
1
A new editorial paper titled "Therapeutically harnessing cancer stem cell-derived exosomes" has been published in Oncotarget.
Jan 3, 2024
0
0
Cancer arises when multiple mutations result in relentless, inappropriate cell growth. But these mutations don't act in isolation. Instead, mutations can influence each other in ways that affect cancer evolution. Researchers ...
Jan 2, 2024
0
29
PET imaging with 68Ga-FAPI can more effectively detect and stage pancreatic cancer as compared with 18F-FDG imaging or contrast-enhanced CT, according to recent research published in the December 2023 issue of The Journal ...
Jan 2, 2024
0
1
Brain and other central nervous system (CNS) cancers are the leading cause of childhood cancer deaths in the United States. This type of cancer is the second most common type of childhood cancer after leukemia.
Dec 29, 2023
0
0
Medical investigators are theorizing that a combination of two treatments that activate myeloid cells may effectively treat a recalcitrant form of pancreatic cancer that thwarts conventional immunotherapy.
